SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Strategies & Market Trends : January Effect 2007 -- Ignore unavailable to you. Want to Upgrade?

To: RockyBalboa who wrote (90)2/12/2007 2:47:54 PM
From: RockyBalboa  Read Replies (1) | Respond to of 94
 
The street sees it differently:

So, working with round numbers, my forecast gets to peak worldwide Nexavar sales of $800 million in both kidney and liver cancers. If Bayer wanted full ownership of the drug, it might pay two to three times sales for the half it doesn't already own, which would work out to an Onyx market value in the range of $1.6 billion to $2.4 billion.


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News